Condition
Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease clinical trials and research
Research outlook What's coming for Alzheimer's disease: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 8 Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease clinical trials that are recruiting, at sites in 4 countries (most in United States (5), Canada (1), United Kingdom (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 4Countries
Newest Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease clinical trials
All recruiting trials (8)
-
LIFU to Help Sleep and Amyloid Reduction in Older Adults with Cognitive Impairment
A wearable ultrasound device (ATTN201) is being tested to see if it’s safe and easy to use for people 65 and older with mild cognitive impairment and amyloid buildup.
-
Longitudinal profiling of plasma-derived glial extracellular vesicles in Alzheimer's disease
This study tests whether plasma glial extracellular vesicles and neuroinflammation biomarkers change over time across the Alzheimer’s disease spectrum and whether these signals relate to amyloid, tau, and neurodegeneration, with an additional step of exposing healthy iPSC-derived neurons to vesicles to see potential ne
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Non-invasive brain stimulation to try to improve memory in early Alzheimer's
Scientists test whether repetitive transcranial magnetic stimulation to the cerebellum can help short-term memory in people with early Alzheimer's disease compared with a sham procedure.
-
Leronlimab for brain inflammation in Alzheimer's disease
This study will test whether weekly injections of leronlimab are safe and can reduce brain inflammation in people over 50 with Alzheimer's disease or mild cognitive impairment due to Alzheimer's.
-
Mindfulness meditation for improving cognition in older adults
This study is testing whether mindfulness meditation can help older adults, including those with mild cognitive impairment, improve their thinking, memory, and overall quality of life.
-
Using infrared light to improve memory in people with mild cognitive impairment
This study is testing if using infrared light therapy can help improve memory in people with mild cognitive impairment from Alzheimer's disease.
-
Coverage with evidence development for anti-Aβ mAb treatment in Alzheimer's patients
This study is testing how well a new Alzheimer's treatment works and its safety by tracking the progress of people with mild Alzheimer's or mild cognitive impairment over two years.
Related topics
Quick answers
How many Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (5 trials), Canada (1 trial), United Kingdom (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.